Abstract
Results: During the 40-month study period, we identified 1,370 children with influenza including 966 (71%) inpatients. Among 1,368 patients with birth information, 490 (36%) were 10 days, there were twice as many episodes in children aged < 24 months (n = 30) compared with those in the rest of the age groups of patients combined (n = 15). The mean total direct cost associated with laboratory-confirmed influenza was $1,205. Stratified by LOS groups, the mean total direct cost for LOS of 1—5 days was $874 compared to that of $1415 for LOS of 6—10 days. The mean direct costs for treatment, testing, and admission were $319, $383, and $441, respectively. Conclusions: More than three-quarters of pediatric influenza occurred within the first five years of life. The economic burden of this disease in Korea suggests the need to consider inclusion of infants and toddler in annual routine influenza immunization program.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
